1
Lisa A. de Jong, Judith J. Gout-Zwart, Jelena Stevanovic, Harrie Rila, Mike Koops, Menno V. Huisman, Maarten J. Postma
Veröffentlicht in: TH Open, Vol 02, Iss 03, Pp e315-e324 (2018);
2018
Veröffentlicht in: TH Open, Vol 02, Iss 03, Pp e315-e324 (2018);
2018
2
de Vries, T.A.C., Hemels, M.E.W., Cools, F., Crijns, H.J.G.M., Yperzeele, L., Vanacker, P., Blankoff, I., Lancellotti, P., Mairesse, G.H., de Veer, A., Arroyo, R.C., Catez, E., de Pauw, M., Vanassche, T., de Asmundis, C., Kirchhof, P., De Caterina, R., de Groot, J.R., ETNA-AF-Europe, P.r.i.n.c.i.p.a.l.
Veröffentlicht in: de Vries , T A C , Hemels , M E W , Cools , F , Crijns , H J G M , Yperzeele , L , Vanacker , P , Blankoff , I , Lancellotti , P , Mairesse , G H , de Veer , A , Arroyo , R C , Catez , E , de Pauw , M , Vanassche , T , de Asmundis , C , Kirchhof , P , De Caterina , R , de Groot , J R , ETNA-AF-Europe , P R I N C I P A L & ETNA-AF-Europe principal investigators from Belgium and the Netherlands 2021 , ' Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study ' , Netherlands Heart Journal , vol. 29 , no. 3 , pp. 158-167 . https://doi.org/10.1007/s12471-020-01518-7;
2021
Veröffentlicht in: de Vries , T A C , Hemels , M E W , Cools , F , Crijns , H J G M , Yperzeele , L , Vanacker , P , Blankoff , I , Lancellotti , P , Mairesse , G H , de Veer , A , Arroyo , R C , Catez , E , de Pauw , M , Vanassche , T , de Asmundis , C , Kirchhof , P , De Caterina , R , de Groot , J R , ETNA-AF-Europe , P R I N C I P A L & ETNA-AF-Europe principal investigators from Belgium and the Netherlands 2021 , ' Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study ' , Netherlands Heart Journal , vol. 29 , no. 3 , pp. 158-167 . https://doi.org/10.1007/s12471-020-01518-7;
2021
3
4
Jacobs, Maartje S, Schouten, Jeroen F, de Boer, Pieter T, Hoffmann, Mikael, Levin, Lars-Åke, Postma, Maarten J
Veröffentlicht in: Jacobs , M S , Schouten , J F , de Boer , P T , Hoffmann , M , Levin , L-Å & Postma , M J 2018 , ' Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands ' , Current Medical Research and Opinion , vol. 34 , no. 10 , pp. 1839-1847 . https://doi.org/10.1080/03007995.2018.1459528;
2018
Veröffentlicht in: Jacobs , M S , Schouten , J F , de Boer , P T , Hoffmann , M , Levin , L-Å & Postma , M J 2018 , ' Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands ' , Current Medical Research and Opinion , vol. 34 , no. 10 , pp. 1839-1847 . https://doi.org/10.1080/03007995.2018.1459528;
2018
5
De Jong, Lisa A., Gout-Zwart, Judith J., Stevanovic, Jelena, Rila, Harrie, Koops, Mike, Huisman, Menno V., Postma, Maarten J.
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018